top
Search terms
Results 1 - 8 of 8 - ordered by :
Ejhf

Serum aldosterone is associated with mortality and re‐hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial Introduction ...

European Journal of Heart Failure, Girerd, Nicolas, Pang, Peter S., Swedberg, Karl, Fought, Angela, Kwasny, Mary J., Subacius, Haris, Konstam, Marvin A., Maggioni, Aldo, Gheorghiade, Mihai, Zannad, ...

Date : 01/11/2013 Item size : 177224 bytes
Ejhf

Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial Introduction In the last ...

European Journal of Heart Failure, Mentz, Robert J., Allen, Bradley D., Kwasny, Mary J., Konstam, Marvin A., Udelson, James E., Ambrosy, Andrew P., Fought, Angela J., Vaduganathan, Muthiah, O'Connor, ...

Date : 01/01/2013 Item size : 177809 bytes
Ejhf

[1] While DM is associated with increased cardiovascular morbidity and mortality in ambulatory patients with chronic systolic HF,[2],[3] its influence as an independent predictor of long-term ...

European Journal of Heart Failure, Sarma, Satyam, Mentz, Robert J., Kwasny, Mary J., Fought, Angela J., Huffman, Mark, Subacius, Haris, Nodari, Savina, Konstam, Marvin, Swedberg, Karl, Maggioni, Aldo ...

Date : 01/02/2013 Item size : 192634 bytes
Ejhf

The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial[11]−[13] provides a unique opportunity to perform an in-depth characterization of LFTs during ...

European Journal of Heart Failure, Ambrosy, Andrew P., Vaduganathan, Muthiah, Huffman, Mark D., Khan, Sadiya, Kwasny, Mary J., Fought, Angela J., Maggioni, Aldo P., Swedberg, Karl, Konstam, Marvin ...

Date : 01/03/2012 Item size : 189922 bytes
Ejhf

Serum aldosterone is associated with mortality and re‐hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial Introduction ...

European Journal of Heart Failure, Girerd, Nicolas, Pang, Peter S., Swedberg, Karl, Fought, Angela, Kwasny, Mary J., Subacius, Haris, Konstam, Marvin A., Maggioni, Aldo, Gheorghiade, Mihai, Zannad, ...

Date : 01/11/2013 Item size : 185922 bytes
Ejhf

Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial Introduction In the last ...

European Journal of Heart Failure, Mentz, Robert J., Allen, Bradley D., Kwasny, Mary J., Konstam, Marvin A., Udelson, James E., Ambrosy, Andrew P., Fought, Angela J., Vaduganathan, Muthiah, O'Connor, ...

Date : 01/01/2013 Item size : 181719 bytes
Ejhf

The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial[11]−[13] provides a unique opportunity to perform an in-depth characterization of LFTs during ...

European Journal of Heart Failure, Ambrosy, Andrew P., Vaduganathan, Muthiah, Huffman, Mark D., Khan, Sadiya, Kwasny, Mary J., Fought, Angela J., Maggioni, Aldo P., Swedberg, Karl, Konstam, Marvin ...

Date : 01/03/2012 Item size : 196565 bytes
Ejhf

[1] While DM is associated with increased cardiovascular morbidity and mortality in ambulatory patients with chronic systolic HF,[2],[3] its influence as an independent predictor of long-term ...

European Journal of Heart Failure, Sarma, Satyam, Mentz, Robert J., Kwasny, Mary J., Fought, Angela J., Huffman, Mark, Subacius, Haris, Nodari, Savina, Konstam, Marvin, Swedberg, Karl, Maggioni, Aldo ...

Date : 01/02/2013 Item size : 194730 bytes